Six Drugs on the Horizon

[Guest guest]

On The Horizon – A Status Report of Six

New Promising Advancing Treatments for Men with Advanced Prostate Cancer as of the Beginning of June, 2010at www.advancedprostatecancer.net-- T Nowak MA, MSWDirector for Advocacy and  Advanced Prostate Cancer Programs, Malecare Inc.

Men Fighting Cancer, TogetherSurvivor - Recurrent Prostate, Thyroid, Melanoma and Renal Cancerswww.advancedprostatecancer.net - A blog about advanced and recurrent prostate cancer

www.malecare.com - information and support about prostate cancerhttp://health.groups.yahoo.com/group/advancedprostatecancer/ - an online support group for men and their families diagnosed with advanced and recurrent prostate cancer

[Guest guest]

Nowak wrote:

> On The Horizon - A Status Report of Six New Promising Advancing

> Treatments for Men with Advanced Prostate Cancer as of the

> Beginning of June, 2010 at www.advancedprostatecancer.net

> http://advancedprostatecancer.net/?p=1622

One thing that I found interesting in this report of six new

drugs is that they include five different kinds of therapy,

including:

Chemotherapy (cabazitaxel)

Cancer vaccine (Prostvac)

Testosterone inhibitor (abiraterone, TAK700)

Testosterone uptake blocker (MDV3100)

Internal bone radiation (Alpharadin)

It is possible that MDV3100 won't work if abiraterone or TAK700

don't work, but the others all attack the cancer in different

ways. It would seem, in theory at least, that a patient could

try one, get all the benefit from it that he gets, then try the

next one, and so on. Using a drug from one of the categories

should not (again in theory) develop any resistance to any of the

others.

So this is better news than any one of the drugs by itself would

represent.

Alan